Patents by Inventor Thomas Gesner

Thomas Gesner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070293491
    Abstract: New compounds capable of acting as CDC7 inhibitors are provided. The compounds are useful either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of CDC7 mediated diseases, such as cancer. The compounds have the Formula (I) or (II), where the values of the variables are defined herein.
    Type: Application
    Filed: April 13, 2007
    Publication date: December 20, 2007
    Applicant: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
    Inventors: Cynthia Shafer, Annette Walter, Mika Lindvall, Thomas Gesner, Laura Doyle
  • Publication number: 20060025570
    Abstract: Novel polypeptides of human megakaryocyte stimulating factors (MSFs). Pharmaceutical compositions containing same, and methods for their preparation and use are provided.
    Type: Application
    Filed: June 28, 2005
    Publication date: February 2, 2006
    Inventors: Katherine Turner, Steven Clark, Kenneth Jacobs, Rodney Hewick, Thomas Gesner
  • Publication number: 20050256157
    Abstract: Compounds of Structure I, and salts, tautomers, stereoisomers, and mixtures thereof may be used in methods of inhibiting checkpoint kinase 1 in subjects, in methods for inducing cell cycle progression, and in methods for increasing apoptosis in cells. Such compounds may be used to prepare pharmaceutical compositions and may be used in conjunction with DNA damaging agents.
    Type: Application
    Filed: January 21, 2005
    Publication date: November 17, 2005
    Inventors: Thomas Gesner, Paul Barsanti, Stephen Harrison, Zhi-Jie Ni, Nathan Brammeier, Yasheen Zhou, Vincent Le